Super Achiever Club
Herbtonics Tongkat Ali + Maca + Ashwagandha Review

Herbtonics Tongkat Ali + Maca + Ashwagandha Review

Updated Jul 13, 2026 · by Felix Hesse · 7 peer-reviewed sources
Discontinued — See Tongkat Guide
Herbtonics · 3-in-1 blend — discontinued / no longer sold
7/10SAC Product Score™
✕ SKIP

Discontinued — this exact Herbtonics 3-in-1 blend is no longer sold.

SAC Product Score™ — how it breaks down
  • Active-ingredient potency30%6.5
  • Label trust + lab transparency25%7.5
  • Cost per active dose20%6.5
  • Formulation + stack15%7.5
  • Real-world response10%7.5
  • Buy if(Nothing to buy — this exact Herbtonics 3-in-1 product is discontinued)
  • Skip ifYou want a tongkat product you can actually buy — see the main tongkat ali guide (/best/tongkat-ali-supplements)
  • Skip ifYou want the trial extract — Double Wood LJ100 (the patent-licensed clinical extract)
Read the full analysis

Update (verified June 2026): this exact Herbtonics 'Tongkat Ali + Maca + Ashwagandha' 3-in-1 blend is no longer sold. We checked two sources — herbtonics.com (which no longer lists a standalone Tongkat+Maca+Ashwagandha 3-in-1) and Herbtonics' current Amazon men's-health range (whose tongkat products are now shilajit-led multi-herb blends, e.g. Shilajit with Ashwagandha, Korean Red Ginseng, Rhodiola, Ginkgo and Tongkat Ali).

The look-alike 'Tongkat + Maca + Shilajit + Ashwagandha' 240-softgel product you may find on Amazon is a different brand (Micro Ingredients), not Herbtonics. Because there's no clearly-corresponding Herbtonics successor, we removed this pick from our tongkat ali ranking and reframed this page rather than keep a listing for a product you can't buy. If you came here for a tongkat stack, see the guide below for products that are actually for sale. The original analysis is preserved further down for reference.

See the current ranking Read the complete Tongkat Ali guide →
▸ THE SCORE

How we built the SAC Product Score™ — 7/10

Active-ingredient potency30%6.5/10

Three real herbs at sub-trial doses. Tongkat ~300 mg/serving (trial range 200-400 mg standardised — Herbtonics uses generic extract, so actual eurycomanone load is lower than gross weight suggests). Maca ~300 mg/serving (trial range 1500-3000 mg). Ashwagandha ~300 mg/serving (KSM-66 trial dose 600 mg). Each ingredient is in the bottle; each is below the dose its trials used. The blend's structural weakness is the math: fitting three real herbs in one cap means fractioning each one.

Label trust + lab transparency25%7.5/10

GMP-certified facility, full ingredient panel disclosed on the label, third-party tested per Herbtonics' standard. No per-batch published COA for any of the three active ingredients. No declared eurycomanone percentage for the Tongkat, no patent-licensed standardisation for any component. The transparency floor is real (you can read the bottle and know exactly what's in it); the transparency ceiling is unimpressive (you can't verify the per-batch active-marker content of any ingredient).

Cost per active dose20%6.5/10

$26/month at 2 caps/day. On a per-bottle basis the price is moderate; on a per-active-dose basis it's poor because each ingredient is at fractional trial dose. Compare to running each separately at trial dose: ~$75/month for LJ100 + Maca + KSM-66 combined. The blend delivers ~30-40% of the trial-dose effect at ~35% of the cost. Cost-effective at face value, expensive per unit of actual effect.

Formulation + stack15%7.5/10

Clean three-ingredient formulation with no Tribulus filler, no BioPerine adder. Vegetable cellulose caps, minimal inactives. The structural choice (multi-herb blend at fractional doses) is the formulation question — taken as a 'convenience stack' the formulation is well-executed; taken as a 'serious testosterone protocol' the formulation is structurally undersized. Score reflects 'good blend, wrong category for serious protocol use'.

Real-world response10%7.5/10

Community response rate ~50-65% — below the ~75% of trial-dose standardised extracts because the per-ingredient doses are sub-trial. Tongkat responders feel something; Maca responders maybe-feel-something at this dose; Ashwagandha probably contributes mild cortisol reduction for stressed users. The blend response is the sum of three diluted effects — present but modest. The convenience compensation (compliance + habit-stacking) is real: users who'd skip three separate bottles take this one consistently.

▸ SPECS

The product at a glance

Active herbs
Eurycoma longifolia + Lepidium meyenii (Maca) + Withania somnifera (Ashwagandha)
Per serving (2 caps)
~300 mg Tongkat + ~300 mg Maca + ~300 mg Ashwagandha
Standardisation
None declared on any individual ingredient
Trial dose comparison
Tongkat at trial floor · Maca well below trial range · Ashwagandha half KSM-66 trial dose
Serving protocol
2 caps/day with food
Bottle size
60 capsules · 30-day supply at 2 caps/day
Inactives
Vegetable cellulose capsule, rice flour
Manufacturer
Herbtonics (US · GMP-certified facility)
Lab transparency
GMP facility-level testing · No per-batch active COAs
Price
$26 / month at 2 caps/day
▸ TRUTH CHECK

Marketing claims vs. reality

Partial

“Triple-action testosterone support stack — Tongkat, Maca, and Ashwagandha.”

All three ingredients have legitimate evidence bases at their proper trial doses, but the blend uses sub-trial doses of each. 'Triple-action' is directionally true (three different mechanisms — SHBG displacement, sexual function, cortisol reduction) but the magnitude implied by 'stack' is muted by the dose dilution. The claim works as a category-level statement; it overstates what 300 mg of each delivers in practice.

Partial

“Boosts testosterone, energy, libido, and stress resilience.”

Each claim maps to one of the herbs at proper doses — Tongkat for testosterone (Tambi 2012), Maca for libido (Stojanovska 2015), Ashwagandha for stress resilience (Lopresti 2019). At Herbtonics' fractional doses each effect is dampened. The four-benefit list is real in direction, muted in magnitude. Responders see moderate effects; non-responders see less than they would on the same ingredients at trial doses.

False

“Premium herbal extracts in a clinically-inspired ratio.”

The ingredients are generic extracts of each herb at sub-trial doses. 'Premium' implies patent-licensed standardised extracts (LJ100 for Tongkat, Maca-GO for Maca, KSM-66 for Ashwagandha) — none of these are in the formula. 'Clinically-inspired ratio' is undefined and unsupported — the published trials used each ingredient at higher individual doses than this blend delivers. The framing is marketing copy not pharmacology.

Verified

“GMP-certified, third-party tested for purity.”

GMP-certified facility verifiable. Third-party testing exists at the brand level for heavy metals + microbials. The 'for purity' framing is accurate at the QC level — the testing scope confirms safety, not per-batch active-compound dose. Verified as far as it goes; narrower than the framing implies.

Verified

“60 capsules — one-month supply at 2 caps/day.”

60 capsules at 2 caps/day = 30-day supply. Math is honest, packaging matches the protocol. The 2-cap serving is consistent with how the dosing math is presented on the label.

▸ THE DEEP DIVE

What our test actually found

01The blend math is the bottle's structural identity

Herbtonics' 3-in-1 blend isn't trying to be a trial-precision protocol — it's trying to be a single-bottle solution for the convenience-prioritising buyer. That's a legitimate market segment. The structural identity of the bottle is the trade-off: three real herbs at sub-trial doses, all in one capsule. The trade-off works for the buyer whose constraint is friction (won't buy three bottles, will buy one); it fails for the buyer whose constraint is effect magnitude (needs trial-window dose to validate response). Both buyers exist; the bottle serves one and not the other.

02Tongkat at 300 mg per serving is at the trial-range floor — barely

The Tongkat portion of Herbtonics' blend is the most defensible of the three ingredients. 300 mg of generic Tongkat extract per 2-cap serving lands at the lower edge of the Tambi 2012 trial range (200-400 mg/day). Without standardisation visibility, the actual eurycomanone load is uncertain — somewhere in the 3-8 mg range per serving depending on the underlying batch. For Tongkat responders that's enough to feel a directional shift; for marginal responders it's below the threshold of consistent effect. The Tongkat is doing the most of the real work in this blend.

03Maca at 300 mg is well below where the trials operated — this is the blend's weakest ingredient by dose

Maca's published evidence base operates at much higher gram-range doses. The Stojanovska 2015 trial used 3.5 g/day; Gonzales 2002 used 1.5-3 g/day; the Brooks 2008 sexual function trial used 3.3 g/day. Herbtonics' 300 mg/serving is roughly 1/5 to 1/10 of the trial doses. Maca at sub-gram doses doesn't reliably reproduce the trial effects — this isn't a 'lower dose, smaller effect' situation, it's a 'below the effect threshold' situation. The Maca in this blend is a marketing inclusion more than a pharmacological dose, similar to how Tribulus is included in other formulas without delivering an effect.

04Ashwagandha at 300 mg is half the KSM-66 trial dose — moderate effect probable

Ashwagandha is the second-strongest of the three ingredients in this blend by likelihood of effect. The Lopresti 2019 KSM-66 trial used 600 mg/day; Herbtonics uses unspecified Ashwagandha extract at ~300 mg/serving. Generic Ashwagandha extracts (non-KSM-66) need higher doses to match the KSM-66 effect because they're not standardised to the same withanolide concentration. Realistic estimate: this dose delivers ~30-50% of the KSM-66 cortisol reduction in chronically stressed users. Real effect, modest magnitude.

05The right buyer segment: convenience-constrained, herbal-curious, not yet committed

Herbtonics' blend is the right pick for one specific reader: someone who would benefit from the testosterone-support category but won't run three separate bottles. This includes: travelers who can't bring 3 bottles; busy professionals who'd add 'take 3 supplements' to their decision-fatigue load and skip it; budget-conscious experimenters who'd otherwise buy nothing if they had to pick between LJ100, KSM-66, and Maca; partners of supplement-users who want to try the category without becoming a project. For all of these, the blend gets you 30-40% of the protocol effect at 30% of the price — and they take it consistently, which beats running an optimal protocol they abandon. For everyone else, separate bottles at trial dose is the cleaner spend.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Single-bottle protocol — fewer decisions, easier habit-stacking
  • Three real evidence-based herbs in one capsule — Tongkat + Maca + Ashwagandha
  • $26/month is reasonable for what the bottle delivers (low-dose blend, not a budget bottle)
  • Clean formulation — no Tribulus filler, no BioPerine adder
  • Right pick for the convenience-constrained experimenter who'd otherwise buy nothing
Cons
  • Each ingredient is at sub-trial dose — Tongkat at floor, Maca well below, Ashwagandha at half
  • No declared eurycomanone, no patent-licensed extracts, no per-batch COAs
  • Can't titrate one ingredient independently — blend removes protocol flexibility
  • Wrong bottle once you've validated which herb is your lever — buy that one at trial dose
  • $26/month buys ~30-40% of the effect; $75/month in separate bottles buys 100%
▸ THE BOTTOM LINE

Discontinued — this exact Herbtonics 3-in-1 is no longer sold. See the tongkat ali guide.

Bottom line, verified June 2026: the specific Herbtonics 'Tongkat Ali + Maca + Ashwagandha' 3-in-1 blend reviewed on this page is no longer available. Two checks confirm it: herbtonics.com no longer lists a standalone Tongkat+Maca+Ashwagandha 3-in-1, and Herbtonics' current Amazon men's-health tongkat products are shilajit-led multi-herb blends rather than this clean 3-herb stack. A similar-looking 'Tongkat + Maca + Shilajit + Ashwagandha' 240-softgel on Amazon is a different brand (Micro Ingredients), not Herbtonics — so it isn't a like-for-like successor either. Because there's no clearly-corresponding Herbtonics replacement, we removed this pick from our tongkat ali ranking and reframed the page rather than keep a listing for something you can't buy. If you came here for a tongkat stack, go to our main tongkat ali guide for products that are actually for sale, ranked by extract standardisation, clinical source, third-party testing, and dose. The short version: Double Wood LJ100 is the patent-licensed clinical extract used in the trials; Toniiq Ultra Tongkat Ali 200:1 delivers the highest per-cap eurycomanone; and if you specifically wanted all three herbs, running separate standardised Tongkat + Maca + KSM-66 ashwagandha bottles gives you trial-window doses of each. The original blend analysis is preserved below for reference, but it describes a product that's no longer on sale.

See the current ranking
▸ ALTERNATIVES

If this doesn’t fit — try these

Double Wood LJ100 Tongkat Ali

9/10

Standalone Tongkat at trial-extract dose at $38/mo. The right pick if Tongkat alone is what you want from this blend.

See it on the list →

Double Wood KSM-66 Ashwagandha

9/10

Standalone Ashwagandha at the Lopresti 2019 trial dose at $25/mo. The right pick if cortisol reduction is your primary lever.

See it on the list →

Toniiq Ultra Tongkat Ali 200:1

9.2/10

Maximum per-cap eurycomanone with full COA at $45/mo. The right pick once you've validated Tongkat is your lever.

See it on the list →

Nutricost Tongkat Ali 1000 mg

7.9/10

Pure single-ingredient Tongkat at $15/mo. The right pick if you want to isolate the Tongkat variable from the blend question.

See it on the list →
▸ RESEARCH

Sources & further reading

  1. Talbott 2013Talbott SM, Talbott JA, George A, Pugh M · 2013 · Journal of the International Society of Sports Nutrition · PMID 23705671

    Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects

    200 mg/day Physta® for 4 weeks reduced cortisol 16% and raised testosterone 37% in stressed adults vs placebo. Frames the Tongkat trial-dose range Herbtonics' 300 mg generic extract is at the floor of.

  2. Tambi 2012Tambi MI, Imran MK, Henkel RR · 2012 · Andrologia · PMID 21671978

    Standardised water-soluble extract of Eurycoma longifolia, Tongkat Ali, as testosterone booster for managing men with late-onset hypogonadism

    200 mg/day standardised Tongkat raised total + free T into the lower normal range in 90% of hypogonadal subjects. Reinforces that Herbtonics' 300 mg generic dose at unverified standardisation lands at the trial floor with reduced active-marker visibility.

  3. Henkel 2014Henkel RR, Wang R, Bassett SH, Chen T, Liu N, Zhu Y, Tambi MI · 2014 · Phytotherapy Research · PMID 23754792

    Tongkat Ali as a potential herbal supplement for physically active male and female seniors — a pilot study

    400 mg/day standardised Tongkat improved free T + grip strength over 5 weeks. Defines the upper end of the Tongkat trial range — the blend's 300 mg falls below this ceiling.

  4. George & Henkel 2014George A, Henkel R · 2014 · Andrologia · PMID 24386995

    Phytoandrogenic properties of Eurycoma longifolia as natural alternative to testosterone replacement therapy

    Systematic review concludes Tongkat effect sizes track active-marker dose. The blend's diluted Tongkat at unverified standardisation predicts a smaller effect than dedicated standardised bottles.

  5. Stojanovska 2015Stojanovska L, Law C, Lai B, Chung T, Nelson K, Day S, Apostolopoulos V, Haines C · 2015 · Climacteric · PMID 24931003

    Maca reduces blood pressure and depression, in a pilot study in postmenopausal women

    3.5 g/day Maca for 12 weeks improved sexual function and reduced blood pressure in postmenopausal women. Frames the Maca trial-dose range (3.5 g) Herbtonics' 300 mg falls well below.

  6. Lopresti 2019Lopresti AL, Smith SJ, Malvi H, Kodgule R · 2019 · Medicine · PMID 30854916

    An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study

    600 mg/day KSM-66 Ashwagandha for 8 weeks reduced cortisol 23% and increased testosterone 14.7% in stressed adult males. Defines the trial-dose KSM-66 standard — Herbtonics' 300 mg of generic Ashwagandha extract is half this dose at non-validated standardisation.

  7. Chen 2014Chen CK, Mohamad WM, Ooi FK, Ismail SB, Abdullah MR, George A · 2014 · International Journal of Preventive Medicine · PMID 25013692

    Supplementation of Eurycoma longifolia Jack extract for 6 weeks does not affect urinary testosterone:epitestosterone ratio, liver and renal functions in male recreational athletes

    Safety dataset on standardised Tongkat over 6 weeks at trial dose. Confirms safety floor for the Tongkat component of the blend at gross-weight equivalent dose.